Home

ACB

Aurora Cannabis Inc.

NASDAQHealthcareDrug Manufacturers - Specialty & Generic

$3.41

-0.58%

2026-05-08

About Aurora Cannabis Inc.

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers pharmaceutical-grade cannabis products; medical and consumer cannabis products; and engages in the propagation of vegetables and floral plants. It also provides dried and fresh cannabis, cannabis oils, trims, concentrates, ingestibles, capsules, vaporizers, edible cannabis, cannabis extracts, and cannabis topicals; and patient counseling and outreach services. Its brand portfolio includes San Rafael '71, Greybeard, Drift, Daily Special, Being, CanniMed, MedReleaf, Aurora, and WMMC, as well as international brands include Pedanios, Bidiol, IndiMed, and CraftPlant. The company was founded in 2013 and is headquartered in Edmonton, Canada.

Key Fundamentals

Forward P/E

-31.41

EPS (TTM)

$-1.10

ROE

-15.5%

Revenue Growth (YoY)

6.8%

Profit Margin

-22.5%

Debt/Equity

17.79

Price/Book

0.50

Beta

1.33

Market Cap

$204.3M

Avg Volume (10D)

978K

Recent Breakout Signals

No recent breakout signals detected for ACB.

Recent Price Range (60 Days)

60D High

$4.13

60D Low

$3.07

Avg Volume

937K

Latest Close

$3.41

Get breakout alerts for ACB

Sign up for Breakout Scanner to receive daily notifications when ACB triggers breakout signals. Build custom AI screeners and backtest strategies.

Start Free Trial

7-day free trial. No card required.

Aurora Cannabis Inc. (ACB) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors ACB daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. ACB operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry. Data is provided for informational purposes only and does not constitute financial advice.